- Home
- EFR vs ALDX Comparison
EFR vs ALDX Comparison
Compare EFR & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFR
- ALDX
- Stock Information
- Founded
- EFR 2003
- ALDX 2004
- Country
- EFR United States
- ALDX United States
- Employees
- EFR N/A
- ALDX N/A
- Industry
- EFR Trusts Except Educational Religious and Charitable
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- EFR Finance
- ALDX Health Care
- Exchange
- EFR Nasdaq
- ALDX Nasdaq
- Market Cap
- EFR 342.8M
- ALDX 296.0M
- IPO Year
- EFR N/A
- ALDX 2014
- Fundamental
- Price
- EFR $11.17
- ALDX $5.06
- Analyst Decision
- EFR
- ALDX Strong Buy
- Analyst Count
- EFR 0
- ALDX 2
- Target Price
- EFR N/A
- ALDX $9.50
- AVG Volume (30 Days)
- EFR 88.6K
- ALDX 654.8K
- Earning Date
- EFR 01-01-0001
- ALDX 11-05-2025
- Dividend Yield
- EFR 9.43%
- ALDX N/A
- EPS Growth
- EFR N/A
- ALDX N/A
- EPS
- EFR 1.69
- ALDX N/A
- Revenue
- EFR N/A
- ALDX N/A
- Revenue This Year
- EFR N/A
- ALDX N/A
- Revenue Next Year
- EFR N/A
- ALDX $63.48
- P/E Ratio
- EFR $7.74
- ALDX N/A
- Revenue Growth
- EFR N/A
- ALDX N/A
- 52 Week Low
- EFR $10.95
- ALDX $1.14
- 52 Week High
- EFR $13.29
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- EFR 35.50
- ALDX 46.91
- Support Level
- EFR $11.09
- ALDX $4.53
- Resistance Level
- EFR $11.27
- ALDX $5.35
- Average True Range (ATR)
- EFR 0.10
- ALDX 0.29
- MACD
- EFR -0.00
- ALDX 0.01
- Stochastic Oscillator
- EFR 15.38
- ALDX 61.82
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.